In a surprising move that has divided the pharmacy profession, the General Pharmaceutical Council (GPhC) has sanctioned hundreds of pharmacies to allow
patients to self-select certain Pharmacy (P) medicines, a decision met with strong opposition from the Royal Pharmaceutical Society (RPS) as well as from the
Pharmacy Defense Association (PDA).
In a statement, RPS shared that at a board meeting held on 19th June, they expressed "disappointment" over what they described as a lack of prior consultation
and comprehensive communication from the GPhC regarding the implications of this policy shift.
They argue that allowing patients to self-select certain P medicines could potentially jeopardize established professional guidelines and compromise the role of
pharmacists in ensuring safe medication use.
"Enabled by the General Pharmaceutical Council, we understand that hundreds of pharmacies, from large multiples to small independents, have been approved by the
regulator to enable patients to self-select certain P medicines," the statement said.
The General Pharmaceutical Council (GPhC) has launched a new draft 'Equality Guidance' for pharmacies to tackle discrimination and make sure that everyone can access safe and effective person-centred pharmacy care.
GPhC's consultation is seeking views on "the structure and language of the guidance, if anything is missing and the impacts on patients and members of the public, pharmacy staff, pharmacy owners, and individuals or groups sharing any of the protected characteristics."
The regulator said the draft guidance is designed to support pharmacy owners to:
demonstrate that they are meeting our standards for registered pharmacies
fulfil their legal and regulatory duties in relation to equality
help protect the rights of individuals
advance equal opportunities for staff, patients and the wider public
help improve the experience and healthcare outcomes of patients and members of the public.
Blackwells Chemist, a community pharmacy in South East London did not meet all the General Pharmaceutical Council (GPhC) standards.
The pharmacy was inspected on Thursday (01 June) and it was found it did not keep all its records up to date and accurate, particularly its responsible pharmacist
records. Investigation report stated that the principle of Governance and principle of Services, including medicines management was 'not met at all'.
Under the principle Governance, the report stated: "The pharmacy generally manages the risks associated with its services adequately. People using the pharmacy can
provide feedback or raise concerns. And staff generally protect people's personal information well. Team members know what to do to help protect the welfare of a
vulnerable person. The pharmacy has written procedures, but these are not easily accessible to team members to refer to. And they are not regularly updated. So,
they may be less useful to staff, and may not reflect current best practice."
In the inspection it was found that the pharmacy does not always store its medicines properly. It cannot show that it stores all its medicines requiring cold
storage at the appropriate temperatures.
The professional leadership body for pharmacists has urged the General Pharmaceutical Council's (GPhC) to make it mandatory to have a chief pharmacist within
organisations to ensure transparency for patients, the public and pharmacy staff.
On 23 January, the GPhC launched a consultation seeking views on the new draft Standards for Chief Pharmacists it has developed to strengthen pharmacy governance.
These standards outlined the professional responsibilities and qualifications required by a chief pharmacist to support their organisation and its staff to deliver
"safe and effective" pharmacy services.
The pharmacy regulator highlighted the importance of having a registered chief pharmacist meeting these standards in hospitals (or relevant settings) to benefit
from the new legislation regarding accidental errors.
In response to the consultation, the RPS expressed that while meeting these standards could enhance pharmacy governance, they may not provide the framework needed
to fully support staff in reporting and learning from errors.
Duncan Rudkin, the CEO of the General Pharmaceutical Council (GPhc) has highlighted the importance of strengthening pharmacy governance to provide clarity
around how pharmacies are organised and managed.
This will ensure that patients and the public continue to receive safe and effective pharmacy care, he said while speaking at the annual Sigma Conference in
London on Sunday (5 November).
According to him, there could be rules that outlined the essential roles and responsibilities of responsible pharmacists, and professional standards for
responsible pharmacists, superintended pharmacists and chief pharmacists.
He also announced that the GPhC will be shortly launching a consultation to integrate a new set of standards for the statutory role of hospital chief
pharmacists "which up until recently has never been recognised in law." It is expected to be launched by early January 2024.
However, Duncan, emphasised that they cannot start the work on standards for responsible and superintendent pharmacists until they know the government plans
in relation to supervision.
"Because of course, the responsible pharmacists' regime, and the supervision regime are in many ways intertwined, and can't certainly be looked at separately.
The General Pharmaceutical Council (GPhC) has removed a pharmacist from its register who black-marketed 'zolpidem' along with another pharmacist between 2015
and 2016.
Dean Zainool Dookhan, a pharmacist first registered with the Royal Pharmaceutical Society of Great Britain on 18 October 2004 and whose registration was later
transferred to the General Pharmaceutical Council under registration number 2059808, was jailed last year for exporting 20,000 packets of zolpidem to the Caribbean.
While hearing the case on 24-25 May, GPhC's Fitness to Practise Committee stated that "removal of the Registrant's name from the register is the appropriate and
proportionate response to his convictions."
"The public interest includes protecting the public, maintaining public confidence in the profession, and maintaining proper standards of behaviour. The Committee
is entitled to give greater weight to the public interest than the Registrant's own interest in remaining on the register."
"The Committee recognises the sanction has a punitive effect in that the Registrant's ability to practise and earn an income as a pharmacist and 28 his professional
reputation will be curtailed; it will be five years before he can seek restoration to the register. However, that is the price he must pay for failing to comply with the fundamental tenets of his profession."
The General Pharmaceutical Council (GPhC) has raised concerns over the rising risks related to online pharmacy services.
It revealed over 30 per cent of its open Fitness to Practise (FtP) cases were related to online pharmacy, which is disproportionate to the sector of the market that
online services occupy.
The regulator has advised pharmacists and pharmacy owners providing online services that they should "not work with online providers who try to circumvent the
regulatory oversight put in place within the UK to ensure patient safety".
In the past five months, the Council has imposed seven interim orders on the registration of pharmacists who have worked for or with online prescribing services -
after identifying serious concerns with their practice.
It said: "These pharmacists were working as pharmacist independent prescribers for online services or were dispensing medicines prescribed online. Some of these
pharmacists were the Responsible Pharmacist (RP) or the Superintendent Pharmacist (SP)."
The General Pharmaceutical Council (GPhC) has urged health and care professionals to meet relevant regulatory standards amidst the shortage of GLP-1 receptor
agonists (GLP-1 RAs).
The council said: "We are concerned to hear that people with Type 2 diabetes are experiencing problems accessing GLP-1 receptor agonists (GLP-1 RAs). We know that
these are being widely prescribed for weight loss purposes and in some cases prescribed off-label."
"We recognise the adverse impact that shortages and supply chain issues can have on patients, the public and wider health and care teams.
The Council understands that health and care professionals are using their professional judgement and making decisions in challenging situations, balancing a range
of factors such as individual patient needs, wider public health and pressures and limitations on available resources such as medicines shortages or other supply
chain issues.
The Royal Pharmaceutical Society's (RPS) second roundtable on workforce wellbeing resulted in a series of collaborative actions to address pharmacy
professionals' mental health and wellbeing challenges.
The roundtable brought together key stakeholders from the pharmacy sector, including organisations like the General Pharmaceutical Council (GPhC), Community
Pharmacy England (CPE), the National Pharmacy Association (NPA), and the profession's independent charity Pharmacist Support (PS).
A report detailing the outcomes of the meeting was published on Friday, highlighting the key areas of discussion and the agreed-upon actions by the participants.
During the roundtable, participants discussed the importance of understanding the workforce demographics, both nationally and locally, and using data to address
wellbeing issues effectively.
They also emphasised the need for using supportive standards set by the General Pharmaceutical Council (GPhC) and the Care Quality Commission (CQC) quality
statement to support and empower pharmacists' wellbeing positively.
Just over 60 per cent candidates have passed the first four-country common registration assessment for pharmacists, held jointly by the General Pharmaceutical Council (GPhC) and Pharmaceutical Society of Northern Ireland (PSNI).
Out of a total of 959 candidates who sat the assessment in four countries on 16 November, 584 candidates have passed - recording an overall pass rate of 60.9 per cent.
The registration assessment is one of the ways trainee pharmacists can demonstrate that they understand how to apply knowledge appropriately and in a timely way, to make professional judgements in pharmacy practice.
Passing the registration assessment is a vital element of being eligible to apply to become a registered pharmacist.
In the November assessment, 43 per cent candidates sat for the first time, 45 per cent for the second time and 12 per cent for the third time.
Online pharmacies have to operate from bricks & mortar premises that are registered with the General Pharmaceutical Council, but recent cases show that, in
reality, the practices of online pharmacies are often very different to other pharmacies, and the regulation of online pharmacies is also different - and evolving
as issues arise.
For a start, the General Pharmaceutical Council (GPhC) is only one of the regulators taking an interest in online pharmacy services. Other regulators include the
Medicines and Healthcare products Regulatory Agency (MHRA) which enforces the advertising and promotion of medicines, and the Care Quality Commission (CQC) which
regulates prescribing services.
The different regulation of online pharmacies is attributable to the higher risk to patients and the public from medicines bought online. These risks often arise
from a combination of patients who do not tell the truth in order to obtain medicines and the nature of a transaction in which a pharmacist does not see patients
face-to-face.
"The GPhC has strong enforcement powers that it uses when it considers its premises standards have not complied with."
However, there are also things that go wrong because pharmacists have simply failed to act professionally or take sufficient care, as well as cases where things
have gone wrong through misfortune.
Today I'm proud to share with you the statement we submitted to the UK Commission on Pharmacy Professional Leadership in which we set out what professional
leadership means to RPS.
I recognise we haven't always been clear in communicating our ideas to members and our external stakeholders. Through the Commission, and our own Independent
Review of member participation and communications, we are determined to remedy this.
We're committed to lead pharmacy in the best interest of patients and the professions. This means that sometimes we will need to take difficult decisions. We will
do the right thing for the long term, ultimately driving what's best for patient care.
There are some key changes we believe are necessary to fulfil the profession's ambitions.
To achieve a more unified approach to pharmacy leadership, we believe both pharmacists and pharmacy technicians should be represented by RPS within professional
faculties that capitalise on the strengths of each discipline whilst retaining distinct professional voices.
Many of our members work with pharmacy technicians every day and know just how essential they are to their role and to patient care. We feel the same at RPS and it
makes perfect sense to evolve into an organisation where both professions can advance their scope of practice, working in alignment as part of the wider
multi-professional team.
We will develop and implement post-registration curricula and credentialing for all pharmacists and pharmacy technicians working with patients and the public. To
do this we will require formal delegation of authority by the GPhC.
The implementation of the 2017 standards for the initial education and training of pharmacy technicians (IETPT) has improved the performance and
preparedness for practice among recently registered pharmacy technicians and the wider workforce, according to a new study.
Results of the 2023 research study commissioned by the General Pharmaceutical Council (GPhC) showed that 72 per cent of pharmacy technicians felt "well prepared"
for practice after training. More number of pharmacy technicians in the community pharmacy expressed readiness for practice (82 per cent) than their peers in the
hospital pharmacy (64 peer cent).
Led by the Centre for Pharmacy Workforce Studies (CPWS) at the University of Manchester and the consultancy service, ICF, the study involved 142 recently registered
pharmacy technicians and 21 employers and supervisors of trainees.
Overall, 96 per cent of the surveyed respondents believed that the course effectively covered person-centred care, professionalism and professional knowledge and
skills.
Thorrun Govind, a former chair of the English Pharmacy Board of the Royal Pharmaceutical Society, has joined Brabners' regulatory & professional conduct team.
With nearly a decade of experience as a GPhC-registered pharmacist, Govind will provide guidance on regulatory and professional conduct issues.
Govind's expertise extends to healthcare advisory and disputes involving NHS Trusts and social care organisations.
She has been recognised as the 'Young Pharmacist of the Year' by Pharmacy Business Magazine and is a frequent commentator on public health and healthcare law
for major television networks.
Her appointment underscores Brabners' commitment to offering top-tier legal services to the healthcare industry.
A judicial review claim launched by the British Medical Association (BMA) against the General Medical Council (GMC) has parallelly intensified Pharmacists'
Defence Association's (PDA) scrutiny over the use of the term 'pharmacy professionals'.
PDA has criticised the evolving definition of 'pharmacy professionals,' and the potential risks to patient safety amidst regulatory ambiguity as part of "a far
wider agenda."
Concerns stem from what the PDA perceives as a blurring of distinctions between pharmacists and pharmacy technicians as "attempted homogenisation" by bodies like
the General Pharmaceutical Council (GPhC), NHS, and Royal Pharmaceutical Society (RPS).
Raising similar issue as the BMA against the GMC over its use of 'medical professionals for doctors and Medical Associate Professions (MAPs), Mark Koizol,
Chairman of the PDA has said:
The General Pharmaceutical Council's Fitness-to-Practise (FtP) committee has reversed its earlier decision ruling that a London pharmacist's statement,
attributing the Grenfell tragedy to "Zionist supporters of the Tory party," amounted to the propagation of anti-Semitic tropes.
In an initial 2020 hearing, the FtP committee found that a set of remarks delivered by Nazim Hussain Ali, Managing Partner of Chelsea Pharmacy Medical Clinic,
through a megaphone to a crowd assembled at a Palestinian rights rally in central London in 2017 were deemed "grossly offensive," but not classified as anti-Semitic.
Ali admitted his comments were offensive, but he was cleared of accusations of antisemitism and received a first warning on November 5, 2020.
However, the High Court overturned this decision in June 2021 following an appeal by the Professional Standards Authority as the Judge found evidence of
a "serious procedural or other irregularity" in the FtP committee's decision and instructed the GPhC to reopen the case.
The Pharmacists' Defence Association (PDA) has raised the issue faced by the pharmacy students on returning to in-person assessments while urging the
universities to take an empathetic approach in transition of online to in-person exams.
It was highlighted by the association that many student members were apprehensive about the return to in-person assessments. This is due to their continuing worry of Covid-19 transmissions and anxiety caused by changing exam formats and procedures.
However, with the ease of Covid restrictions, now pharmacy schools are able to decide how exams are conducted but the PDA believes that they should communicate the
process to students in advance.
"A return to normal university life is considered to be beneficial to student health and well-being. In-person exams are an important part of preparing for students' future trainee assessment examinations, GPhC accreditation for pharmacy schools, and ensuring the integrity of exam results. As future healthcare professionals, face-to-face interaction is also an integral part of the role," said the PDA.
To help transform care for patients, the Royal Pharmaceutical Society (RPS) is calling on the General Pharmaceutical Council (GPhC) to remove the two-year post qualification wait for pharmacists before they are allowed to start their independent prescriber training.
RPS proposes that entry to training should be based on whether pharmacists can evidence the necessary skills, knowledge, and experience to undertake the training, and not the length of time a pharmacist has been on the register.
RPS president Claire Anderson said: "We've campaigned strongly for better use of pharmacist independent prescribers, who are becoming essential to multi professional teams in all health care settings.
"We want to ensure pharmacy remains an attractive career and has parity with the other professions. Pharmacist prescribing is now moving from being a skill only associated with advanced specialist levels of practice to a more generalist scope, providing a workforce that's more flexible with a shared set of capabilities.
The Department of Health and Social Care (DHSC) has published plans to amend current pharmacy legislation on dispensing errors and clarify how registered
pharmacies are governed.
The Department's response to a public consultation on rebalancing medicines legislation and pharmacy regulation programme first proposed in summer 2018 was
delayed due to Brexit and the Covid-19 pandemic.
The programme aims to clarify and strengthen the organisational governance arrangements of registered pharmacies, specifically to define and clarify the core
purpose of the Responsible Pharmacist and Superintendent Pharmacist roles.
It will also give the General Pharmaceutical Council (GPhC) powers to define in professional standards how those roles are fulfilled.
The General Pharmaceutical Council reiterated its stand on Covid-19 vaccination, saying, "Pharmacists and pharmacy technicians working in all settings across Great Britain should be vaccinated against Covid -19, unless they are medically exempt."
In a statement issued today (February 11), it strongly urged all pharmacyprofessionals, students and trainees to get fully vaccinated at the earliest.
This reiteration follows the government's announcement on January 31, 2022 that it would not proceed with Covid vaccination as a mandatory condition of deployment
for health and care staff providing CQC-regulated services in England.
The Council stated that clinical trials have proven the efficacy and safety of Covid vaccines and the Medicines and Healthcare products Regulatory Agency (MHRA) has authorised their use in the UK.